Back to search results

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma · Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Jana Hall) · jana_hall@med.unc.edu · 919-843-3550
    Contact: Study coordinator (Lynn Ruffin) · lynn_ruffin@med.unc.edu · 919-843-7130
    Contact: Principal Investigator (Sascha A Tuchman, MD)

  • Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Principal Investigator (Reed Friend, MD)

  • Duke Comprehensive Cancer Center, Durham, North Carolina, United States

    Contact: Study coordinator (Jennifer Tichon, BSN) · jennifer.tichon@duke.edu · 919-660-7262
    Contact: Study coordinator (Samantha Soares, BSN) · samantha.soares@duke.edu · (919) 660-6319
    Contact: Principal Investigator (Christina Costa, DO)

  • Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina, United States

    Contact: Study coordinator (Helen Walton, RN) · Helen.Walton@novanthealth.org · 910-667-7677
    Contact: Principal Investigator (Swaleh Bahamadi, MD)

  • The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Golda Danquah) · Golda.Danquah@osumc.edu
    Contact: Principal Investigator (Srinivas Devarakonda, MD)
Study leads

  • Sascha Tuchman, MD

    Principal Investigator

    UNC Lineberger Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)